Helix Pharma (Pvt.) Ltd.
Syed Farhan Ehtesham is an experienced professional in the field of validation and engineering, currently serving as the Assistant Manager of Validation at Helix Pharma (Pvt.) Ltd. since October 2021. Previously, Syed worked as a Senior Officer in Validation at AGP (Private) Limited, where responsibilities included performing Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) on production equipment and utilities, as well as participating in automation projects involving PLCs. Early career experience includes an engineering internship at Afroze Textiles Industries Pvt. Ltd., focusing on mechanical and electrical issues with clothing machinery, and another internship at K-Electric, specializing in instrumentation and turbine maintenance. Syed holds a Bachelor's degree in Mechatronics Engineering from the Shaheed Zulfikar Ali Bhutto Institute of Science and Technology and has completed pre-engineering studies at Govt. Dehli College, as well as a Middle School Diploma in Computer Science from St. Patrick's High School in Karachi.
This person is not in any teams
This person is not in any offices
Helix Pharma (Pvt.) Ltd.
2 followers
Helix Pharma Private Limited is a Pakistan based pharmaceutical company incorporated in the year 1960, member of the Hakimsons Group established since 1921, principally engaged in the manufacture of life saving drugs. A technical collaboration in 1965 with Takeda Pharmaceutical Company of Japan was forged to build a world class pharmaceutical factory. The group’s journey in the last 100 years has been one that has gone through many political and economic cycles and has stood witness to the scientific evolution in medicine as well as very dramatic change in the regulations that primarily govern the pharmaceutical industry. Adapting to these changes has been a key factor in our success, as has been the ability to remodel our operations to best meet the needs of the medical community. Our commitment to preserving the environment and our support to local communities through health and educational initiatives affords us an opportunity to give back society in the spirit of compassion and shared human values. In order to reduce our carbon foot print we are in the process of converting 80% of the electricity needs of all our industrial and commercial facilities to renewable energy. In the next seven years we anticipate our complete fleet of vehicles will go electric. Several government registered local charities are recipients of our grant that include hospitals, school, blood banks and other special interest initiatives. Pharmaceuticals Portfolio: In addition to an extensive range of branded generics that cover 75% of all therapeutic classes and products manufactured under license, we have a range of imported biological and oncology drugs. Herbals / Nutraceuticals: Our range of nutraceutical/herbal proprietary formulations has been developed, tested and marketed with an aim to capture the growing and promising area of Alternative Medicine. Investing in the right direction is essential for a sustainable tomorrow...